Attovia Therapeutics, Inc. (ATTO) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Attovia Therapeutics, Inc. (ATTO) closed at USD 13.73 on 2026-10-16, a change of -37.3 % over the past year, with a market capitalization of USD 634.1M.

Attovia Therapeutics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Attovia Therapeutics, Inc. key figures

Previous close

USD 13.73 (2026-10-16)

1-year change

-37.3 %

Market cap

USD 634.1M

Enterprise value

USD 781.52M

P/E ratio (trailing)

-5.07

P/E ratio (forward)

-5.84

EPS (trailing)

-2.74

EPS (forward)

-2.38

PEG ratio

n/a

Price to book

-0.43

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.24

Employees

44

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Attovia Therapeutics, Inc.

Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments. The company's products include ATTO-1310, a novel ATTOBODY-based Fc-fusion protein therapeutic that inhibits IL-31; developed for the treatment of chronic pruritic diseases such as CPUO, high-itch AD, cholestatic pruritus, and CKD-aP; ATTO-2306, an ATTOBODY-based, half-life-extended immunoglobulin G (IgG)-fusion protein therapeutic that inhibits IL-13 and IL-31; developed for the treatment of AD and other immune-mediated skin diseases, such as CSU and PN; and ATTO-1091, a trispecific ATTOBODY-based Fc-fusion protein therapeutic that inhibits TL1A, IL-23, and integrin a4ß7; developed for IBD a chronic immune-mediated condition characterized by persistent inflammation of the gastrointestinal tract, includes ulcerative colitis (UC) and crohn's disease (CD). The company was incorporated in 2022 and is based in San Carlos, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Attovia Therapeutics, Inc. and compare it with other stocks.